POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells

European Journal of Cancer Prevention

Volumn 19, Issue 5, 2010, Pages 345-351

  Ning, Xiaoyan ^a   Yang, Shiming ^a   Wang, Rongquan ^a   Zhang, Rugang ^a   Guo, Liping ^a   Tie, Jun ^a   Cheng, Yongbo ^a   Wang, Guoan ^a   Wan, Shunmei ^a   Fang, Dianchun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

gastric cancer; POT1 protein; RNA interference

Indexed keywords

PROTEIN; PROTEIN POT1; TANKYRASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG; POT1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TELOMERASE; TELOMERE BINDING PROTEIN; TNKS PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL AGING; CELL PROLIFERATION; COLONY FORMATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE; STOMACH ADENOCARCINOMA; TELOMERE; ADENOCARCINOMA; CELL SURVIVAL; DEFICIENCY; GENETICS; METABOLISM; STOMACH TUMOR; TUMOR CELL CULTURE; ULTRASTRUCTURE;

ADENOCARCINOMA; CELL SURVIVAL; GENE EXPRESSION; HUMANS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TANKYRASES; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TUMOR CELLS, CULTURED;

EID: 77955276851     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833b4812     Document Type: Article

References (34)

1. Baumann P, Cech TR (2001). Pot1, the putative telomere end-binding protein in fission yeast and human. Science 292:1171-1175.
2. Baumann P, Podell E, Cech TR (2002). Human Pot1 (Protection of Telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol Cell Biol 22:8079-8087.
3. Cawthon RM (2002). Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47.
4. Chandra A, Hughes TR, Nugent CI, Lundblad V (2001). Cdc13 both positively and negatively regulates telomere replication. Genes Dev 15:404-414.
5. Churikov D, Wei C, Price CM (2006). Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection. Mol Cell Biol 26:6971-6982.
6. Colgin ML, Baran K, Baumann P, Cech TR, Reddel RR (2003). Human POT1 facilitates telomere elongation by telomerase. Curr Biol 13:942-946.
7. De Lange T (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100-2110.
8. Fujii K, Sasahira T, Moriwaka Y, Oue N, YasuiW, Kuniyasu H (2008). Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer. Int J Mol Med 21:599-604.
9. Gomez D, Wenner T, Brassart B, Douarre C, O'Donohue MF, El Khoury V, et al. (2006). Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J Biol Chem 281:38721-38729.
10. Grandin N, Damon C, Charbonneau M (2000). Cdc13 cooperates with the yeast Ku proteins and Stn1 to regulate telomerase recruitment. Mol Cell Biol 20:8397-8408.
11. Hockemeyer E, Sfeir AJ, Shay JW, Wright WE, de Lange T (2005). POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J 24:2667-2678.
12. Hockemeyer D, Daniels JP, Takai H, de Lange T (2006). Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 126:63-77.
13. Iwano T, Tachibana M, Reth M, Shinkai Y (2004). Importance of TRF1 for functional telomere structure. J Biol Chem 270:1442-1448.
14. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T (1999). p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321-1325.
15. Kondo T, Oue N, Yoshida K, Mitani Y, Naka K, Nakayama H, et al. (2004). Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 64:523-529.
16. Lei M, Zaug AJ, Podell ER, Cech TR (2005). Switching human telomerase on and off with hPOT1 protein in vitro. J Biol Chem 280:20449-20456.
17. Lin SY, Elledge SJ (2003). Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113:881-889.
18. Lin X, Gu J, Lu C, Spitz MR, Wu X (2006). Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res 12:5720-5725.
19. Loayza D, Parsons H, Donigian J, Hoke K, de Lange T (2004). DNA binding features of human POT1: a nonamer 50-TAGGGTTAG-30 minimal binding site, sequence specificity, and internal binding to multimeric sites. J Biol Chem 279:13241-13248.
20. Ma Y,Wu L, Liu C, Xu L, Li D, Li JC (2009). The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population. J Cancer Res Clin Oncol 135:431-437.
21. Makarov VL, Hirose Y, Langmore JP (1997). Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88:657-666.
22. Muramatsu Y, Tahara H, Ono T, Tsuruo T, Seimiya H (2008). Telomere elongation by a mutant tankyrase1 without TRF1 poly(ADP-ribosyl)ation. Exp Cell Res 314:1115-1124.
23. Nikitina T, Woodcock CL (2004). Closed chromatin loops at the ends of chromosomes. J Cell Biol 166:161-165.
24. O'Connor MS, Safari A, Xin H, Liu D, Songyang Z (2006). A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc Natl Acad Sci USA 103:11874-11879.
25. Shakirov EV, Surovtseva YV, Osbun N, Shippen DE (2005). The Arabidopsis Pot1 and Pot2 proteins function in telomere length homeostasis and chromosome end protection. Mol Cell Biol 25:7725-7733.
26. Smith S, Giriat I, Schmitt A, de Lange T (1998). Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282:1484-1487.
27. Van Steensel B, De Lange T (1997). Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743.
28. Veldman T, Etheridge KT, Counter CM (2004). Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr Biol 14:2264-2270.
29. Wang X, Wang X, Gao H, Liao X, Lian X (1997). The effect of p53 on the malignant growth of human gastric carcinoma cell line BGC823. Chin Biochem 13:46-49.
30. Wang F, Podell ER, Zaug AJ,Yang Y, Baciu P, Cech TR, et al. (2007). The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445:506-510.
31. Wu L, Multani AS, He H, Cosme-Blanco W, Deng Y, Deng JM, et al. (2006). Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126:49-62.
32. Xin H, Liu D,Wan M, Safari A, Kim H, Sun W, et al. (2007). TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445:559-562.
33. Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP (2008). Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Eur J Cancer Prev 17:209-217.
34. Ye YZ, Hockemeyer D, Krutchinsky AN, Loayza D, Hooper SM, Chait BT, et al. (2004). POT1-interacting proteinPIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev 18:1649-1654.